DuPont de Nemours (NYSE:DD - Get Free Report) had its target price reduced by equities research analysts at Citigroup from $59.00 to $56.00 in a research note issued to investors on Monday,MarketScreener reports. The brokerage presently has a "buy" rating on the basic materials company's stock. Citigroup's price target would suggest a potential upside of 18.84% from the stock's previous close.
A number of other brokerages have also recently commented on DD. Deutsche Bank Aktiengesellschaft lifted their price objective on DuPont de Nemours from $46.00 to $58.00 and gave the stock a "buy" rating in a research note on Wednesday, February 18th. Wolfe Research raised their target price on DuPont de Nemours from $49.00 to $54.00 and gave the stock an "outperform" rating in a report on Wednesday, February 11th. Zacks Research upgraded DuPont de Nemours from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 12th. Argus cut their price target on shares of DuPont de Nemours from $86.00 to $52.00 and set a "buy" rating on the stock in a research report on Thursday, February 5th. Finally, KeyCorp lifted their price objective on shares of DuPont de Nemours from $51.00 to $57.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, DuPont de Nemours currently has an average rating of "Moderate Buy" and a consensus price target of $51.66.
View Our Latest Stock Analysis on DuPont de Nemours
DuPont de Nemours Trading Down 0.3%
Shares of NYSE DD opened at $47.12 on Monday. The company's 50 day simple moving average is $47.11 and its 200 day simple moving average is $41.66. DuPont de Nemours has a fifty-two week low of $24.48 and a fifty-two week high of $52.66. The firm has a market capitalization of $19.27 billion, a P/E ratio of -25.33, a P/E/G ratio of 1.18 and a beta of 1.09. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.42 and a quick ratio of 1.91.
DuPont de Nemours (NYSE:DD - Get Free Report) last released its earnings results on Tuesday, February 10th. The basic materials company reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. The firm had revenue of ($1,871.00) million during the quarter, compared to analyst estimates of $1.69 billion. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The business's quarterly revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.13 EPS. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. On average, analysts predict that DuPont de Nemours will post 4.38 EPS for the current year.
Institutional Investors Weigh In On DuPont de Nemours
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Salomon & Ludwin LLC lifted its stake in DuPont de Nemours by 186.5% in the 3rd quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company's stock valued at $25,000 after purchasing an additional 207 shares during the last quarter. Palisade Asset Management LLC bought a new stake in DuPont de Nemours during the 3rd quarter worth approximately $26,000. Financial Life Planners acquired a new position in DuPont de Nemours in the 3rd quarter valued at approximately $27,000. Imprint Wealth LLC bought a new position in shares of DuPont de Nemours during the third quarter valued at $27,000. Finally, Measured Wealth Private Client Group LLC acquired a new position in shares of DuPont de Nemours during the third quarter worth $30,000. 73.96% of the stock is owned by institutional investors.
About DuPont de Nemours
(
Get Free Report)
DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.